Evidence map›Paper›PMID 28573495›Full record

ArticleFamilial cancer2018

RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.

Lochlan J Fennell, Mark Clendenning, Diane M McKeone, Saara H Jamieson, Samanthy Balachandran, Jennifer Borowsky, John Liu, Futoshi Kawamata, Catherine E Bond, Christophe Rosty and 4 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Familial cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022
    Article
  5. Review
  6. Article
  7. Review
  8. Cancers · 2020
    Article
  9. Structure-guided design fine-tunes pharmacokinetics, tolerability, and antitumor profile of multispecific frizzled antibodies.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Lochlan J FennellConjoint Gastroentrology Laboratory, Level 7 CBCRC, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, 4006, QLD, Australia.
Mark ClendenningGenetic Epidemiology Laboratory, Colorectal Oncogenomics Group, Department of Pathology, The University of Melbourne, Parkville, VIC, Australia.
Diane M McKeoneConjoint Gastroentrology Laboratory, Level 7 CBCRC, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, 4006, QLD, Australia.
Saara H JamiesonConjoint Gastroentrology Laboratory, Level 7 CBCRC, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, 4006, QLD, Australia.
Samanthy BalachandranConjoint Gastroentrology Laboratory, Level 7 CBCRC, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, 4006, QLD, Australia.
Jennifer BorowskyConjoint Gastroentrology Laboratory, Level 7 CBCRC, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, 4006, QLD, Australia.
John LiuConjoint Gastroentrology Laboratory, Level 7 CBCRC, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, 4006, QLD, Australia.
Futoshi KawamataConjoint Gastroentrology Laboratory, Level 7 CBCRC, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, 4006, QLD, Australia.
Catherine E BondConjoint Gastroentrology Laboratory, Level 7 CBCRC, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, 4006, QLD, Australia.
Christophe RostyGenetic Epidemiology Laboratory, Colorectal Oncogenomics Group, Department of Pathology, The University of Melbourne, Parkville, VIC, Australia.
Matthew E BurgeRoyal Brisbane and Women's Hospital, Herston, Australia.
Daniel D BuchananGenetic Epidemiology Laboratory, Colorectal Oncogenomics Group, Department of Pathology, The University of Melbourne, Parkville, VIC, Australia.
Barbara A LeggettConjoint Gastroentrology Laboratory, Level 7 CBCRC, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, 4006, QLD, Australia.
Vicki L J WhitehallConjoint Gastroentrology Laboratory, Level 7 CBCRC, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, 4006, QLD, Australia. Vicki.Whitehall@qimrberghofer.edu.au.
QIMR Berghofer Medical Research Institute · AUEnvoi Specialist Pathologists · AUUniversity of Queensland · AURoyal Brisbane and Women's Hospital · AUUniversity of Melbourne · AU

Funding

Data sharing: the Colon Cancer Family Registry CohortU01CA167551 · NCI · UNIVERSITY OF MELBOURNE · PI Daniel David BUCHANAN, Steven Gallinger · 2018 to 2026
$16.8M
Colon Cancer Family Registry CohortUM1CA167551 · NCI · STANFORD UNIVERSITY · PI HAILE, ROBERT WILLIAM, JENKINS, MARK A · 2013 to 2017
$11.3M
AUSTRALASIAN COLORECTAL CANCER FAMILY REGISTRYU01CA097735 · NCI · UNIVERSITY OF MELBOURNE · PI HOPPER, JOHN L · 2002 to 2007
$6.9M
The Colon Cancer Family Registry: AustralasiaU24CA097735 · NCI · UNIVERSITY OF MELBOURNE · PI HOPPER, JOHN L · 2008 to 2011
$6.2M
National Health and Medical Research Council CDFNCI NIH HHS CA167551NCI NIH HHS U01 CA097735NCI NIH HHS U24 CA097735NCI NIH HHS UM1 CA167551
6 · The paper itself

Abstract

The WNT signaling pathway is commonly altered during colorectal cancer development. The E3 ubiquitin ligase, RNF43, negatively regulates the WNT signal through increased ubiquitination and subsequent degradation of the Frizzled receptor. RNF43 has recently been reported to harbor frequent truncating frameshift mutations in sporadic microsatellite unstable (MSI) colorectal cancers. This study assesses the relative frequency of RNF43 mutations in hereditary colorectal cancers arising in the setting of Lynch syndrome. The entire coding region of RNF43 was Sanger sequenced in 24 colorectal cancers from 23 patients who either (i) carried a germline mutation in one of the DNA mismatch repair genes (MLH1, MSH6, MSH2, PMS2), or (ii) showed immunohistochemical loss of expression of one or more of the DNA mismatch repair proteins, was BRAF wild type at V600E, were under 60 years of age at diagnosis, and demonstrated no promoter region methylation for MLH1 in tumor DNA. A validation cohort of 44 colorectal cancers from mismatch repair germline mutation carriers from the Australasian Colorectal Cancer Family Registry (ACCFR) were sequenced for the most common truncating mutation hotspots (X117 and X659). RNF43 mutations were found in 9 of 24 (37.5%) Lynch syndrome colorectal cancers. The majority of mutations were frameshift deletions in the G659 G7 repeat tract (29%); 2 cancers (2/24, 8%) from the one patient harbored frameshift mutations at codon R117 (C6 repeat tract) within exon 3. In the ACCFR validation cohort, RNF43 hotspot mutations were identified in 19/44 (43.2%) of samples, which was not significantly different to the initial series. The proportion of mutant RNF43 in Lynch syndrome related colorectal cancers is significantly lower than the previously reported mutation rate found in sporadic MSI colorectal cancers. These findings identify further genetic differences between sporadic and hereditary colorectal cancers. This may be because Lynch Syndrome cancers commonly arise in colorectal adenomas already bearing the APC mutation, whereas sporadic microsatellite unstable colorectal cancers arise from serrated polyps typically lacking APC mutation, decreasing the selection pressure on other WNT signaling related loci in Lynch syndrome.

Indexed as

Microsatellite InstabilityAdenomaAdenomatous Polyposis Coli ProteinAdultAgedCohort StudiesColorectal NeoplasmsColorectal Neoplasms, Hereditary NonpolyposisDNA-Binding ProteinsDNA Mutational AnalysisFemaleHumansMaleMiddle AgedOncogene ProteinsSelection, GeneticAdenomatous Polyposis Coli ProteinAPC protein, humanDNA-Binding ProteinsOncogene ProteinsRNF43 protein, humanUbiquitin-Protein LigasesColorectal cancerHNPCCLynch syndromeMicrosatellite instabilityMSIRNF43

Identifiers

PMID28573495
PMCPMC6086823
OpenAlexW2621277855

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.